Y-mAbs is a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. 

Biotechnology

Y-mAbs Therapeutics

Thomas Gad

Courtney Dugan

Tore Søderblom

Sune Nyland

Søren Christensen

Rikke Lillesø

René Christensen

Christopher Naylor

Anna Murzhenko, PharmD

Vignesh Rajah

Bo Kruse

Joris Wilms

Sue Smith

The leadership team at Y-mAbs Therapeutics has a long history of experience in the medical and pharmaceutical industries, with many members coming from top companies such as GlaxoSmithKline and Sanofi Aventis UK. The team is also well-educated, with degrees from esteemed universities such as the University of Copenhagen.

Leadership Team

CEO and Executive Team

Board of Directors

Leadership Team

About

Team members

Other teams at Y-mAbs Therapeutics

CEO and Executive Team

Board of Directors